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Changes in the intestinal microbiota have been associated with the development of
immune-mediated diseases in humans. Additionally, the introduction of defined bacterial
species into the mouse intestinal microbiota has been shown to impact on the adaptive
immune response. However, how much impact the intestinal microbiota composition
actually has on regulating adaptive immunity remains poorly understood. Therefore,
we studied aspects of the adaptive immunity in healthy adults possessing distinct
intestinal microbiota profiles. The intestinal microbiota composition was determined
via Illumina sequencing of bacterial 16S rRNA genes extracted from the feces of 35
individuals. Blood B-cell and T-cell subsets from the same individuals were studied
using flow cytometry. Finally, the binding of fecal and plasma Immunoglobulin A (IgA)
to intestinal bacteria (associated with health and disease) Bacteroides fragilis, Prevotella
copri, Bifidobacterium longum, Clostridium difficile, and Escherichia coli was analyzed
using ELISA. Unsupervised clustering of microbiota composition revealed the presence
of three clusters within the cohort. Cluster 1 and 2 were similar to previously-described
enterotypes with a predominance of Bacteroides in Cluster 1 and Prevotella in Cluster
2. The bacterial diversity (Shannon index) and bacterial richness of Cluster 3 was
significantly higher than observed in Clusters 1 and 2, with the Ruminococacceae
tending to predominate. Within circulating B- and T-cell subsets, only Th subsets were
significantly different between groups of distinct intestinal microbiota. Individuals of
Cluster 3 have significantly fewer Th17 and Th22 circulating cells, while Th17.1 cell
numbers were increased in individuals of Cluster 1. IgA reactivity to intestinal bacteria was
higher in plasma than feces, and individuals of Cluster 1 had significant higher plasma IgA
reactivity againstB. longum than individuals of Cluster 2. In conclusion, we identified three
distinct fecal microbiota clusters, of which two clusters resembled previously-described
“enterotypes”. Global T-cell and B-cell immunity seemed unaffected, however, circulating
Th subsets and plasma IgA reactivity were significantly different between Clusters. Hence,
the impact of intestinal bacteria composition on human B cells, T cells and IgA reactivity
appears limited in genetically-diverse and environmentally-exposed humans, but can
skew antibody reactivity and Th cell subsets.
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INTRODUCTION
All mucosal surfaces of the human body are colonized by
microorganisms — termed the human “microbiota” (1). The
number and composition of the microbiota (microbiota profile)
varies greatly dependent on the microbial location on/in the
human host, with variation also being observed at identical
locations within different hosts (2). The total number of bacteria
on/in the human host is estimated at the same order ofmagnitude
as the total number of eukaryotic cells in the human body
(∼3.1013) (3), with the largest microbial load being found in
the intestinal tract, where more than 1,000 bacterial species
may be found (4). The vast majority of intestinal bacteria
appear to be commensals, providing the host with otherwise
inaccessible nutrients, whilst in addition, preventing colonization
and translocation of pathogens within the host (1). The challenge
therefore, is for the host to maintain immunological tolerance
to its resident microbiota without activating inflammatory
processes (5).
In the gut, immunological tolerance is thought to be
maintained via for example, the prevention of bacterial
translocation through the protective intestinal epithelial layer via
the production of mucus, antibacterial peptides and secretory
immunoglobulin A (IgA) (6). IgA is an immunoglobulin that is
“specialized in mucosal protection” (7) and the most abundant
antibody produced and secreted in the human body, mainly
in the intestine (8). The human IGH locus contains two IgA
subclasses, with IgA2 being more resistant to the action of
secreted (neutralizing) bacterial proteases, as it has a shorter
“hinge region” than IgA1 (9). IgA secreting plasma cells can
be generated upon terminal differentiation of activated B cells,
within organized intestinal lymphoid structures with cognate T-
cell help (T-dependent; TD). Alternatively, B cells can mature
into IgA secreting plasma cells following T-cell independent (TI)
activation in the lamina propria (10, 11). Both pathways also
generate IgA memory B cells with TD-derived B cells expressing
CD27 and the TI derived B-cells being CD27-IgA+ (12). Once
secreted, transcytosis of IgA across the gut epithelium transports
it to the lumen of the intestine, where it is able to bind to
bacteria (6). The majority of antibodies produced in the intestine
are antigen-specific (13), with those derived from TI responses
showing a high degree of polyreactivity (14). As is evident
from studies in mice raised in sterile conditions (germ free;
GF), the intestinal microbiota can shape both immunological
tolerance and systemic immunity, resulting in lower IgA levels,
fewer CD4+ and CD8+ T cells and fewer organized lymphoid
structures (Peyer’s patches) in the intestines, as well as fewer
germinal centers in the spleens of GF mice (15).
High-throughput sequencing of the 16S rRNA gene of bacteria
has greatly facilitated research into the inter-individual and inter-
location diversity of the human microbiota (16). Inter-individual
differences in the microbiota appear to be influenced by host
genotype and environmental factors such as diet or antibiotic
use (17–20), with alterations in the intestinal microbiota having
been linked to various immunological diseases such as atopic
disorders, inflammatory bowel disease (IBD), arthritis, type 1
diabetes and multiple sclerosis (MS) (21–25). Nevertheless, the
existence of a “core” human microbiota has been reported, with
individuals being clustered based on the composition/profile
of their microbiota. With respect to the intestinal microbiota,
three clusters (“Enterotypes”), have been observed, dependent
on the relative predominance of the bacterial genera Bacteroides,
Prevotella, and Ruminococcus (26).
Although the great majority of published microbiota studies
have only described various correlations between specific
microbiota profiles and disease, experimental studies using
mouse models have demonstrated that changes in the intestinal
microbiota can actually affect adaptive immune responses.
Specifically, the introduction of specific pathogen free (SPF)
bacteria into germfree (GF) mice has been shown to result in
lower concentrations of interleukin 4 (IL-4), IL-5 and eosinophil
numbers in an OVA-induced allergy model (27). In addition,
administration of probiotic bacteria in these mice reduced serum
IgE levels and Th2 related cytokines, whilst increasing FoxP3
expression in CD4+ T cells in the mesenteric lymph node
(28). Other researchers showed that colonization with segmented
filamentous bacteria (SFB) induced the differentiation of T helper
17 (Th17) cells and regulatory T cells (Treg) (29, 30).
However, these observations were made in inbred animal
models under highly controlled conditions. Therefore, it remains
unclear how well these findings translate to actual microbiota-
immune interactions in humans (31, 32). To gain more insight
into the relationship between the composition of the intestinal
microbiota and associated human immune responses, we studied
the local and systemic adaptive immune response of healthy adult
volunteers harboring distinct intestinal microbiota profiles.
METHODS
Human Subjects
Blood and feces samples of 35 adult individuals were collected
after written informed consent was obtained (Table 1). All
individuals completed a questionnaire to gather information
about Body Mass Index (BMI), diet, habit, intake of antibiotics,
and lifestyle. Individuals with gastrointestinal, auto-immune and
intake of antibiotics in the last 6 months were excluded from the
study. Fecal samples were either frozen immediately at −80◦C
or stored in the fridge overnight before transporting it to the
laboratory. This study was performed in accordance with the
Declaration of Helsinki and the guidelines of the Medical Ethics
Committees of the Erasmus MC.
Intestinal Microbiota Sequencing and
Analysis
Bacterial genomic DNA was isolated from approximately 100mg
feces using the NorDiag-Arrow DNA extraction kit (Autogen,
MA, United States). Next, the V3-V4 region of the 16S rRNA
gene was amplified by PCR (Qiagen, Hilden, Germany) using
the following forward: 5′-ACTCCTACGGGAGGCAGCAG-
3′ and reverse: 5′-ACTACHVGGGTWTCTAAT-3′ primers.
Subsequently, the amplicon (460 bp) was normalized using
the SequalPrep Normalization kit (Thermo Fisher Scientific,
Waltham, MA) and sequenced using the Illumina MiSeq
platform (2X 300PE, v3) (Illumina, San Diego, CA).
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TABLE 1 | Demographics of participants per cluster.
Cluster (n) Cluster 1 Cluster 2 Cluster 3
(n = 7) (n = 8) (n = 20)
Age in yrs (median;
range)
21 (18–35)** 26 (20–46)* 30 (20–38)
Male Gender (n; %) 6 (86.2%) 6 (75.2%) 8 (40.0%)
Allergic (n; %) 5 (71.4%) 3 (37.6%) 10 (50.0%)
Pets in household
(n; %)
3 (42.9%) 2 (25.0%) 7 (35.7%)
Smoking (n; %) 2 (28.6%) 0 1 (5.0%)
Vegetarian (n; %) 1 (14.3%) 0 1 (5.0%)
BMI (median; IQR) 21.04 (19.9–23.5) 22.68 (19.4–23.1) 23.03 (22–24.8)
WBC (median; IQR) 7.1 (4.9–7.5) 7.2 (5.6–10.4) 7.3 (5.7–8.6)
Specific IgE (median;
IQR)
4.23 (0.1–23.6) 0.61 (0.17-22.9) 4.60 (0.02–13.5)
CONSUME REGULARLY
Coffee (n; %) 4 (57.1%) 7 (87.7%) 13 (65.4%)
Probiotics (n; %) 0 0 1 (5.0%)
Alcohol (n; %) 5 (71.4%) 4 (50.0%) 15 (75.2%)
BMI, body mass index in kg/m2; WBC, white blood cell count in million cells/ml; Specific
IgE reactivity against most common airborne allergens,>0.35 is considered positive; IQR,
Interquartile range; yrs, years; consume regularly is defined as at least once a week.
**Cluster 3 vs. Cluster 1 and *Cluster 3 vs. Cluster 2; significant difference calculated
with Mann-Whitney U-test. *P < 0.05; **P < 0.01.
16S profiles were generated using an in-house developed
pipeline. Briefly, singleton reads were discarded. Subsequently,
to normalize for differences in number of reads per sample,
subsampling to 19,000 reads per sample was performed. Similar
16S rRNA gene amplicon sequences with a minimum cluster
identity of 97% were clustered in operational taxonomic units
(OTUs) using UPARSE (USEARCH, v8) (33). OTUs were then
aligned to the SILVA 16S rRNA reference gene database using
RDP classifier v2.2 with a confidence threshold of 0.90 (34, 35).
In a quality control step OTUs with an abundance of <0.005%
were deleted. This Targeted Locus Study project (BioProject
PRJNA515953) has been deposited at DDBJ/EMBL/GenBank
under the accession KCRL00000000. The version described
in this paper is the first version, KCRL01000000. Data
analysis was performed using R studio v3.4.1, Vegan v2.4-5
and Phyloseq v1.22.3 package. Samples were clustered by
unsupervised hierarchical clustering using Bray-Curtis distance
calculations. The robustness of Clusters were assessed by
silhouette validation (36).
Blood Sampling and Flow Cytometric
Immunophenotyping
Peripheral blood (9ml) was obtained from all 35 donors. Samples
were centrifuged for 10min at 820×g to obtain plasma, which
was stored at−80◦C for later use.
Absolute counts of blood CD3+ T cells, CD16+/56+ NK
cells, and CD19+ B-cells were obtained with a diagnostic lyse-
no-wash protocol from 50 µl blood (BD Biosciences, San Jose,
CA). Following red blood cell lysis of 1–2ml blood, detailed
immunophenotyping of B and T cells was performed by 11-color
flow cytometry using fluorochrome-conjugated antibodies listed
in Table S1.
The following subsets were defined within total B
cells (CD19+): naive B cells (CD27-CD38dimIgD+),
Ig class switched memory B cells (CD27-CD38dimIgD-
IgM- and CD27+CD38dimIgD-IgM-) and plasma blasts
(CD27+CD38hi). Furthermore, total IgA+ class switched
memory B cells, as well as IgA1+ and IgA2+ memory
B cells were determined (Figure S3). Within total T cells
(CD3+), CD4+, CD8+, and γδT cell lineages were defined.
Within the CD4+ T-cell lineage, Treg cells (CD25+CD127–),
follicular T helper (Tfh) cells (CD45RA-CXCR5+), Th1 cells
(CD45RA–CCR6−CXCR3+CCR4–), Th2 (CD45RA–CCR6–
CXCR3–CCR4+), Th17.1 (CD45RA–CCR6+CXCR3+CCR4–),
Th17 (CD45RA–CCR6+CXCR3–CCR4+CCR10–) and Th22
cells (CD45RA–CCR6+CXCR3–CCR4+CCR10+) were
identified (Figure S3). Data were acquired on an LSRFortessa
(BD Biosciences) with standardized instrument settings (37) and
analyzed using FacsDIVA software v8 (BD Biosciences).
IgA Isolation From Feces and Plasma
Samples
Approximately five grams of feces were collected from all study
subjects and frozen at −80◦C before use. Feces samples were
thawed and homogenized in 25ml extraction buffer consisting
of Phosphate Buffered Saline (PBS; pH 7.4, 0.5% Tween-20, and
0.5% NaAc) and the mixtures were centrifuged for 20min at
4◦C and 1500×g. Two milliliters of supernatant was taken and
20 µl protease inhibitor cocktail (Sigma-Aldrich, Saint Louis,
MO) added, with the mixture being centrifuged for 10min at
10,000×g. The resulting homogenized feces mixtures were stored
at−20◦C.
IgA isolation from homogenized feces and plasma samples
was performed using Mobicol Affinity Chromatography spin
columns (35µm pores; Mobitec, Göttingen, Germany) with high
affinity for both the IgA1 and IgA2 subclasses. Following filling
of the columns with 100 µl CaptureSelect IgA affinity resin
(Thermo Fisher Scientific), either 500 µl homogenized feces or
200 µl plasma was added to the column and incubated for 1 h.
After three wash steps using PBS pH 7.4, IgA was eluted with
0.1M glycine pH 3.
Quantification of IgA Concentrations and
IgA Reactivity to Bacterial Antigens
IgA concentrations in plasma and feces samples were determined
by ELISA using coating flat-bottom 96-well plates overnight
with 50 µl of 2µg/ml Affinipure goat anti-human IgA α-
chain (Jackson ImmunoResearch, West Grove, PA) in carbonate
buffer. Subsequently, all wells were washed to remove unbound
antibody. Fifty microliters of sample or IgA standard (Sigma-
Aldrich) was added to each well and incubated for 2 h at room
temperature. Bound antibodies were detected using peroxidase-
conjugated goat anti-human IgA (Jackson ImmunoResearch) at a
concentration of 0.8µg/ml in PBS pH 7.4 with 1mM Tris-EDTA
and 0.05% Tween-20 and TMB ELISA substrate (ThermoFisher
Scientific) according to manufacturer’s instructions. Optical
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density (OD) was measured at 450 nm. For each plate, a PBS
only negative control were used to obtain the background signal,
which was subtracted from each sample measurement prior
to calculation of the sample concentration using the standard
curve in Soft-max Pro software v6.4 (Molecular Devices, Silicon
Valley, CA).
To test IgA reactivity, the following bacterial strains were
obtained from Leibniz Institute DSMZ-German Collection of
Microorganisms and Cell Cultures: (1) Bifidobacterium longum
(20088) - Gram positive - one of the earliest colonizers of the
human intestine; (2) Prevotella copri (18205) - Gram negative
- Prevotella enterotype; (3) Clostridium difficile (1296) - Gram
positive - spore-forming potential human pathogen, associated
with diarrhea, and colitis after antibiotic therapy; (4) Bacteroides
fragilis (2151) - Gram positive - Bacteroides enterotype; and
(5) Escherichia coli - Gram negative - the best understood
of all microbiota microorganisms. Axenic culture of bacteria
was performed under recommended conditions on CDC blood
agar with Kanamycin and Vancomycin (BD Biosciences) for P.
copri and on blood agar for all other bacteria. 100 µl bacterial
suspension with OD600 of 0.5 was used to coat flat-bottom 96-
well plates at 4◦C overnight. 25 ng/ml sample IgA, calculated
as mentioned above was used. As positive control IgA isolated
from human colostrum (Sigma-Aldrich) showed reactivity to the
five bacteria tested and was measured at concentrations of 25,
50, and 100 ng/ml on each plate. Absorbance was measured at
450 nm and background signal was subtracted. The absorbance of
each sample was expressed relative to that of the positive control
(mean OD sample/ mean OD pos ct) for normalization and to
enable comparison of results from various samples and those
obtained from different ELISA plates.
Statistics
Statistical analyses were performed using the Mann-Whitney U
test, χ2 test or Kruskal-Wallis, as indicated in the Figure legends.
P < 0.05 were considered statistically significant.
RESULTS
Study Cohort
Thirty-five adult volunteers were included in this study with a
median age of 28 years (range 18–46 years). The study cohort
consisted of 20 males and 15 females with an average BMI of
22.9. Two participants were vegetarian. Total T-, B- , and NK-
cell numbers of all individuals were within the normal range.
Detailed information about the study subjects can be found
in Table S2.
Three Groups of Individuals With Distinct
Intestinal Microbiota Profiles
To study intestinal microbiota profiles, we collected feces
and sequenced the 16S rRNA gene of extracted DNA. We
obtained an average of 44,708 reads (SD = 11,905; range =
19,699−78,703 reads) per sample and identified in total 1,324
OTUs. Subsampling of 19,000 reads per sample yielded a total of
677 OTUs. The predominant phyla in our cohort feces samples
were Bacteroidetes and Firmicutes, in line with previous studies
(2, 38). Within Bacteroidetes, Bacteroidaceae, and Prevotellaceae
were the dominant bacterial families, with the most abundant
bacterial families within the Firmicutes being the Lachnospiraceae
and Ruminococcaceae. Further classification to the genus level
revealed 228 distinct genera of which 57% could be assigned to
a genus. The remaining 43% were assigned to a higher taxonomic
level such as the family, order or class.
The abundance of these 228 genera was used to perform
unsupervised hierarchical clustering with complete linkage based
on Bray-Curtis dissimilarity distance (Figure 1A), and three
distinct clusters were determined by calculating the average
silhouette (36) (Figure S1). The median BMI, White Blood Cell
count (WBC), % of males and allergic individuals did not
significantly differ between the three clusters. The median age of
Cluster 3 is significantly higher than that of Cluster 1 and 2 with
P< 0.01 and P< 0.05, respectively (Table 1). Dietary intake, e.g.,
vegetarian diet, consumption of coffee, probiotics, or alcohol did
not differ between the three clusters, nor did other lifestyle and
environmental factors, such as smoking or pets in the household.
The clustering was not grossly affected by the inclusion of the two
vegetarians in the study cohort, as was shown by unsupervised
clustering after exclusion of vegetarian individuals (Figure S2).
In previous studies, individuals could be clustered into three
distinct enterotypes (26), which was based on the most dominant
bacteria present in their feces, namely Bacteroides, Prevotella
and Ruminococcus. Within our own cohort, individuals in
“Cluster 1” had significantly more Bacteroides in their feces
than individuals in Clusters 2 and 3 (Figure 1B). On the other
hand, Prevotella was significantly more abundant in Cluster 2
than in Clusters 1 and 3. Finally, although Ruminococcus was
not significantly higher in abundance in Cluster 3 individuals
(Figure 1B), a trend could be seen with increased numbers
of Ruminoccocaceae.
To further characterize the composition of the microbiota
within the three clusters detected, we selected the 20
most abundant genera in our cohort and quantified
these per cluster (Figure 2A). The second most abundant
genus in Cluster 1 was from the Lachnospiraceae family
with Bacteroides also being highly abundant in Cluster
2. Of note, Prevotella was undetectable in 4 out of 8
individuals from Cluster 1 and in 5 out of 20 individuals
of Cluster 3. The most abundant genus in the microbiota
of participants in Cluster 3 could not be assigned at
the genus level, but was of the family Ruminococcaceae
(Ruminococcaceae I; Figure 2A). Ruminococcus is part of the
Ruminococcaceae family.
The three clusters differed in bacterial diversity and richness
(Figures 2B,C). Cluster 3 had the most diverse microbiota with
810 unique observed species. This was higher than in Cluster
1 and 2 in which there were 489 and 518 unique species,
respectively (P < 0.0001 and P < 0.01).
Blood T Cells, Memory B Cells and
Microbiota Clusters
The intestinal microbiota in animal models has been shown
to affect IgA+ B cells and CD8+ T cells (39) as well as
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FIGURE 1 | Clustering of individuals based on their microbiota composition. (A) Unsupervised hierarchical clustering based on Bray Curtis dissimilarity of 35 individuals
using all detected bacterial genera (n = 228). Relative abundance of the most abundant genera are shown in the heatmap. When genus name was not assigned, the
family name is given. A cluster of related microbiota profiles was determined as a cut-off value at height 0.7 of the dissimilarity index. Sample numbers given on the
right # indicate vegetarian individuals. (B) Relative abundance of Bacteroides, Prevotella, and Ruminococcus for individuals within each of the three main clusters
defined in A. Each dot represents one individual, red lines are median values. Statistics were calculated with Mann-Whitney U-test. ***P < 0.001; ****P < 0.0001.
CD4+ Th subset numbers (30). Therefore, T- and B-cell
subsets were both analyzed in our human cohort. The total
counts of CD3+ T cells, as well as CD4+, CD8+ and γδT
cells, were similar between individuals of Cluster 1, 2, and 3
(Figure 3A). Multiparameter gating strategies were performed
to define CD4+ T-helper cell subsets (Th1, Th2, Th17, Th17.1,
Th22), and to differentiate follicular helper T cells (Tfh) and
regulatory T cells (Treg) (Figure S4). Th17 and Th22 cells
were significantly lower in individuals of Cluster 3 than to
Clusters 1 and 2 (P < 0.0001 and P < 0.05, respectively).
Th17.1 cells were significantly higher in Cluster 1 than in
Clusters 2 and 3 (P < 0.05 and P < 0.01, respectively).
Absolute numbers of Th1, Th2, Tfh, and Treg subsets, as
well as the Th1/Th2 ratios did not differ significantly between
Clusters (Figure 3A).
Considering the previously published role of secreted
immunoglobulins (Igs) in intestinal immune responses, we
determined the cell counts of total, naive and memory B-cells,
as well as plasmablasts, in peripheral blood. Total B-cell, naive
B-cell and plasmablast counts were similar in individuals with
distinct microbiota composition (Figure 3B). Memory B cells
were defined as CD27+ class-switched (cs; IgD-IgM-) and CD27-
cs memory B cells, and within these subsets, IgA-expressing
memory B cells were defined as CD27+IgA+ and CD27-
IgA+ B cells. CD27-IgA+ memory B-cell numbers were lower
than CD27+IgA+ memory B cells in all 3 Clusters. However,
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Each column shows the median plus interquartile range of the relative abundance of bacterial genera (or if not identified bacterial family), relative abundance of 1.0 =
100%. The numbers below indicate corresponding genus, colors show the bacterial family of the various genera. Ruminococcaceae I, II, and III and Lachnospiraceae I
and II could not be assigned to different genera, but differ in OTU clusters. (B) Shannon diversity index for each of the three clusters to determine bacterial diversity.
(C) Bacterial richness - defined as the total number of observed unique species per cluster. Bars represent median values with interqartile range. Statistics were
calculated with Mann-Whitney U test. **P < 0.01; ***P < 0.001.
these counts did not differ significantly between the 3 Clusters
(Figure 3B). To further distinguish between IgA+ memory B
cells originating in the intestine or at other mucosal surfaces, we
determined the expression of surface IgA1 and IgA2 on blood
B cells (40). The IgA1+/IgA2+ ratios of memory B cells ranged
from 2.5 to 3 and were not significantly different between the 3
Clusters (Figure 3C).
Thus, detailed blood T- and B-cell analysis
showed differences in Th17, Th22, and Th17.1 cells
between individuals with distinct intestinal microbiota
clusters (enterotypes).
Specific IgA to Intestinal Bacteria in Feces
and Plasma
For a more functional analysis of B-cell responses to the
intestinal microbiota, we analyzed the binding of IgA isolated
from feces and plasma samples to indicator human intestinal
bacterial species, including those possessing Gram-positive
and Gram-negative cell walls and associated with health
and disease. These strains included the commensal bacteria
Bacteroides fragilis, Prevotella copri, Bifidobacterium longum
and the potential pathogens Escherichia coli and Clostridium
difficile. Plasma IgA reactivity against all of these bacteria
was higher than fecal IgA reactivity, and all differences,
except for B. fragilis, were statistically significant (P <
0.05) (Figure 4A). The levels of binding of fecal IgA as
assessed by relative absorbance were higher for the commensal
species (Bacteroides fragilis, Prevotella copri, and Bifidobacterium
longum) than for the pathogen C. difficile (Figure 4B). These
differences were nearly all significant, with the exception of
IgA binding levels between B. longum and C. difficile (P
= 0.066). There was a trend in higher fecal IgA binding
to E. coli in individuals of Cluster 2, but this was not
significant (C1 vs. C2, P = 0.054; C2 vs. C3, P = 0.058;
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Figure 4C). Further, fecal IgA reactivity levels did not correlate
to blood CD27+ and CD27-IgA+ memory B-cell counts
(Figure S5).
Relative plasma IgA binding was highest for E. coli, in
contrast to fecal IgA (Figure 4D). IgA binding to B. longum
was lower than binding to the other two commensal bacteria
(B. fragilis and P. copri) in both feces (P = 0.0016 and P =
0.0182) and plasma (P = 0.0105 and P = 0.0009). Plasma
IgA binding to B. longum was lower in individuals of Cluster
2, which was significant when compared to Cluster 1 (P <
0.01) and not significant when compared to Cluster 3 (P =
0.072) (Figure 4E).
The abundance of Prevotella species differed greatly between
individuals, with levels below our protocol detection limit
in 11 cases (<0.005%) to ∼55% of reads (Figures 1B, 2A).
Therefore, we directly compared Prevotella-specific IgA between
11 individuals that showed undetectable levels of Prevotella to
that of Prevotella-carriers. Both fecal and plasma IgA reactivity
did not differ between individuals with (yes) or without (no)
Prevotella as part of their intestinal microbiota (Figure 4F).
Taken together, our results demonstrate that IgA reactivity
to specific intestinal bacteria is detectable in both the feces
and blood plasma of healthy individuals. However, the plasma
IgA levels appear to be higher than fecal IgA levels for
all 5 fecal indicator microorganisms. In addition, the levels
of specific IgA to B. longum were significantly lower in
individuals of Cluster 2 as compared to individuals of
Cluster 1.
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DISCUSSION
As a first step in tackling the complexity of examining effects of
intestinal microbiota profiles on adaptive immunity, we studied
the immune response to 5 indicator bacteria and T- and B-
cell subsets in individuals grouped in 3 defined microbiota
profile clusters. Using this approach, we provide further
evidence that the fecal microbiota composition from healthy
individuals may be grouped into three clusters, characterized
by a dominance of the Bacteroides or Prevotella genera or
the Ruminococcus family as previously reported (26). Whereas,
no differences were apparent in the B-cell compartment, Th
subsets were different between the clusters with Th17 and
Th22 cell numbers being lower in Cluster 3 (Ruminococcus
enterotype), and Th17.1 cells significantly higher in Cluster 1
(Bacteroides enterotype). Intestinal IgA reactivity was similar
between individuals with distinct intestinal microbiota, whereas
plasma IgA reactivity to B. longum was reduced in individuals of
Cluster 2 (Prevotella enterotype).
We found three microbiota clusters, characterized by a
dominance of the Bacteroides or Prevotella genera or the
Ruminococcus family. The classification of specific enterotypes
as three clusters as initially defined by Arumugam et al. (26),
is still debated. Subsequent studies since have reported two,
or even four major clusters (41, 42). The commonly identified
enterotypes in most publications are those clusters defined by
either a higher abundance of Bacteroides or Prevotella species,
with the abundance of Prevotella being linked to diets with a
higher fiber intake and Bacteroides to protein-rich diets (41).
Therefore, Prevotella and Bacteroides have been suggested as
potentially useful biomarkers in studies determining diet and
lifestyle choices in humans (43). We did not observe differences
between individuals with distinct microbiome in the parameters
we collected about food intake. However, we had only a limited
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number of questions about food intake and life style in our
questionnaire and did not include questions to estimate protein
or fiber intake.
In contrast to the initial description of enterotypes, a
significantly higher abundance of bacteria belonging to the
Ruminococcus genus was not observed in our cohort Cluster 3.
Although the family Ruminococcaceae was shown to be most
abundant in this Cluster, we could not be certain that this family
identification comprised bacteria from the genus Ruminococcus
or another genus from the same family. Interestingly, in
previous studies the differences between Bacteroides and
Ruminococcus clusters were shown to be less well-defined than
originally thought, while the Prevotella cluster appears easier to
define (44).
Despite the differences observed in microbiota profiles,
we found no significant differences in blood B-cell subsets.
Previously, infants colonized with E. coli and Bifidobacterium
have been shown to carry more circulating CD20+CD27+
memory B cells in their blood (45). However, in our study, we did
not find alterations of the B-cell compartment in blood between
individuals with distinct intestinal microbiota. The composition
of the intestinal microbiota in children is variable especially in
the first years of life and becomes more stable in adults after
3–5 years (46). This might explain why we did not observe the
types of differences previously reported in infants when using our
adult cohort.
We found reduced Th17.1 cells in individuals of Cluster 2
and 3, as well as lower Th17 and Th22 cells in individuals
of Cluster 3. Studies using mouse models have shown that
segmented filamentous bacteria induce Th17 cell development
(30, 47). In humans, Th17 cells have been described in the
pathogenesis of IBD (48), and reduced Th22 cells were found
in inflamed colon tissue of IBD patients (49). In contrast, Th22
and Th17 cells were increased in rheumatoid arthritis (RA)(50).
Interestingly, in newly diagnosed RA patients Prevotella bacteria
were increased and Bacteroides decreased. More specifically, the
species Prevotella copri was found in 75% of RA patients, while
this was only found in 21% of healthy individuals (24). In healthy
controls we did not found alterations in Prevotella linked to Th17
and Th22 cells.
The balance between Th17 and Treg cells is influenced
by the microbiome and important for the homeostasis in
the gut (51). Han and co-workers have shown that Treg
cell numbers were positively correlated to the abundance
of Ruminococcaceae in the intestine of patients with graft
vs. host disease. However, a decrease in Th17 cells with
increased Ruminococcaceae abundance was not statistically
significant (51). In our cohort were Th17 cells lower in
individuals of Cluster 3 (Ruminococcaceae cluster), which
confirms the trend observed by Han and co-workers. We
did not find a difference in Treg cell numbers between
individuals with high (Cluster 3) and low (Cluster 1
and 2) Ruminococcaceae abundance. Thus, in our cohort
reductions in Th17- and Th22-cell numbers were not linked
to increased Treg numbers, although it is possible that
intestinal cell numbers may differ at specific local sites in
the intestine.
Possible immunomodulatory capacities related to
Ruminococcus and P. copri have not yet been fully described,
although polysaccharide A (PSA) from the capsule of B.
fragilis have been shown to affect systemic Th1/Th2 ratios in
mice (52). Additionally, Round et al. showed that PSA can
alter T-cell differentiation via the induction of Tregs (53).
However, profound differences exist between the microbiota
and immune responses between mice and humans, which
may limit the translation of mouse microbiota studies into the
human situation (54). In our cohort, we found no statistically
significant alterations in Treg numbers or Th1/Th2 ratios in
individuals with a high abundance of Bacteroides in their feces.
This may be explained by the fact that we studied a relatively
small cohort, which might not have been sufficient to detect
more subtle differences in the immune response and microbiota
profiles of human populations that are exposed to many different
interpersonal and environmental influences. Further, we were
not able to identify Bacteroides at the species level, and were
consequently not able to examine differences in the abundance
of B. fragilis between individuals.
Not only bacterial colonization, but also persistent infections
with herpes viruses, esp. CMV and EBV, have been shown
to affect memory T-cell, but not B-cell numbers in peripheral
blood (55–57). These effects included the CD4, CD8, and
γδT cell lineages in CMV positive individuals. As we did not
determine viral seropositivity in our study cohort, we cannot
exclude a confounding effect of CMV infection. However, in
our experience (56), as well as in publications from others, it is
evident that>80–90% of adults are seropositive for CMV.Hence,
it is unlikely that the difference in CMV serostatus would have
affected the changes in T-cell numbers that we observed.
IgA reactivity to 5 indicator bacterial strains was higher
in plasma than in fecal matter, although differences between
individuals with distinct microbiota composition were only
found for plasma IgA reactivity to B. longum. A potential
explanation for higher plasma IgA reactivity as compared to
fecal IgA could be that IgA in the intestine binds commensal
bacteria with low affinity and in a polyreactive manner, possibly
leading to weaker binding in our ELISA assays. In contrast,
systemic immune activation may lead to strong IgA responses
in peripheral blood. For example, it has been shown that
recombinant IgA from intestinal IgA memory B-cells is not only
polyreactive to antigens such as insulin, dsDNA and LPS, but also
against different commensal bacteria (14, 58).
A correlation between IgA and the abundance of the intestinal
bacteria was not found. Although the relative bacterial 16S
rRNA gene quantities calculated are dependent on the number
of 16S rRNA gene copies per bacterial species, we did not
correct for differences in gene copy numbers between all possible
fecal bacteria detected. This was due to the fact that gene
copy numbers vary per individual bacterial species and current
limitations in Illumina sequencing technology mean that it
is not possible to accurately identify bacteria to the species
level. Therefore, differences in 16S rRNA gene copy numbers
could have theoretically influenced our results and masked a
potential correlation between bacterial species abundance and
IgA reactivity. Additionally, our ELISA methodology utilized a
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single representative species of 5 different bacterial genera for
IgA determination, and correlations of IgA activity were obtained
using only a single species from each genus under investigation.
Interestingly, we found Prevotella-reactive IgA antibodies in
plasma and feces of individuals that apparently lacked Prevotella
in the intestinal microbiome. There is a possibility that the
abundance of this genus was below the limit of detection in our
microbiome analysis. Even so, our data shows that individuals
with absent or low abundance of Prevotella in the intestinal
microbiome may still present with high levels of P. copri-
specific IgA in feces and plasma. This is in line with studies
from Hapfelmeier et al. who showed that IgA plasma cells
in the intestine of mice provide long-lasting immunity, with
reactivity up to of 6–8 weeks after their respective target bacteria
were completely cleared from the host (59). In this respect, we
only collected feces at a single time point and changes in the
abundance of Prevotella bacteria in the feces of volunteers could
have taken place over the time of the study. It would have been
interesting to be able to follow our cohort in order to determine
qualitative (presence/absence) changes in the abundance of
Prevotella and other bacterial genera over time.
In our volunteers, systemic (plasma) and intestinal IgA
binding to Bifidobacterium longum was significantly lower than
to other commensals such as Prevotella copri and Bacteroides
fragilis. Bifidobacteria are one of the first bacteria to colonize the
intestine after birth and are beneficial for human health by their
ability to skew T-helper cell responses toward Th1 response (60,
61). Further, in a study in pigs, colonization with Bifodobacterium
and Lactobaccilus induced increased Rota-virus specific intestinal
IgA responses after Rotavirus infection (62), though to our
knowledge, we are the first to describe Bifidobacterium-specific
IgA responses in humans.
In conclusion, we show that plasma IgA reactivity to
5 indicator microorganisms frequently found in the human
intestine is higher than intestinal IgA reactivity. Systemic IgA
reactivity to B. longum is reduced in individuals of Cluster 2
with high abundance of Prevotella in the intestinal microbiome.
Whereas, no differences were observed in the blood B-cell
compartment, Th17-, Th17.1- and Th22-cell numbers were
significantly different between individuals with distinct intestinal
microbiota Cluster profiles (enterotypes). Still, we have studied
a small study cohort and studies involving much larger cohorts,
e.g., population-based cohorts with the potential to correct for
confounding factors such as lifestyle or diet will be required to
confirm our results.
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